Andras Szasz

St. Istvan University

Professor Andras Szasz was born on 04 November 1947 in Budapest, Hungary. He studied physics at Eotvos University and became department leader in 1985. Later he changed the subject to biophysics and worked at St. Istvan University as head of Biotechnics Department.
He was visiting professor at Strathclyde University, Glasgow, UK; at Pazmany Peter Catholic University, Budapest, Hungary and at Chiba University, Chiba, Japan.
He is Chief Scientific Officer of Oncotherm Hungary and Oncotherm Germany.
The number of his publications is 400+ which includes articles and conference abstracts, he is co-author of eight books and 40+ patents. Professor Szasz is the developer of the method ‘oncothermia’.

dont miss

Modulated electrohyperthermia (mEHT) for advanced malignant tumors

mEHT is a selective heating method, targeting the malignant cells and inducing apoptosis for their elimination from the body. The method forms DAMP and induces ICD, making the forming of tumour-specific immune reactions creating abscopal effect possible all over the human body. The method is applicable for all primary or metastatic malignant tumours, also in relapsed or refractory situations. It simultaneously increases the survival time with the quality of life.

EVEN MORE SEMINARS

  • Dr Matt Brown: Speaking at the Oncology Convention

    Dr Matt Brown
    The Royal Marsden Hospital

    Pain in Cancer – New Horizons

  • Dr Shreerang Bhide: Speaking at the Oncology Convention

    Dr Shreerang Bhide
    Royal Marsden Hospital

    Circulating HPV DNA in Locally advanced head and neck cancer.

  • Emlyn Samuel: Speaking at the Oncology Convention

    Emlyn Samuel
    Cancer Research UK

    Brexit: getting the best outcome for research and patients

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Sanjay P Prabhu: Speaking at the Oncology Convention

    Sanjay P Prabhu
    Boston Children’s Hospital & Harvard Medical School

    Evolving role of machine learning in brain tumour imaging